Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q3 2025 | 19.59% |
| Q2 2025 | -4.92% |
| Q1 2025 | 20.82% |
| Q4 2024 | 0.32% |
| Q3 2024 | -84.79% |
| Q2 2024 | 23.32% |
| Q1 2024 | -16.37% |
| Q4 2023 | 4.81% |
| Q3 2023 | -1.49% |
| Q2 2023 | 23.02% |
| Q1 2023 | -28.15% |
| Q4 2022 | 28.58% |
| Q3 2022 | -7.82% |
| Q2 2022 | -18.39% |
| Q1 2022 | 11.00% |
| Q4 2021 | 32.27% |
| Q3 2021 | -9382.68% |
| Q2 2021 | 102.01% |
| Q1 2021 | -47.64% |
| Q4 2020 | 7.53% |
| Q3 2020 | -2050.21% |
| Q2 2020 | 102.29% |
| Q1 2020 | 11.40% |
| Q4 2019 | -39.89% |
| Q3 2019 | 20.96% |
| Q2 2019 | 0.26% |
| Q1 2019 | -391.93% |
| Q4 2018 | 72.12% |
| Q3 2018 | -60.05% |
| Q2 2018 | 45.95% |
| Q1 2018 | -12.07% |
| Q4 2017 | 22.63% |
| Q3 2017 | 14.77% |
| Q2 2017 | 20.38% |
| Q1 2017 | -1.44% |
| Q4 2016 | 3.03% |
| Q3 2016 | 3.03% |
| Q2 2016 | -3.30% |
| Q1 2016 | -36.14% |
| Q4 2015 | 9.61% |